Shareroot appoints new chairman to advance digital health focus

Incoming chairman Dr Julian Chick has more than 25 years of experience in the biotechnology and medical technology industries.

Dr Chick has led both public and private companies

Shareroot Ltd (ASX:SRO) has appointed Dr Julian Chick as chairman, effective May 6 2019, following the resignation of Harvey Kaplan.

Kaplan was appointed in an interim capacity until a suitable chair could be identified and has been pivotal in realigning the company and charting its path forward.

Rebuilding the foundation and recalibrating the strategic direction of the company over the past three months has required a considerable effort from the ShareRoot board, led by Kaplan and newly appointed CEO, Michelle Gallaher.

Dr Chick has background with ShareRoot, as a shareholder and later working as an independent advisor on The Social Science transaction in April 2018 and more recently in the development of the Media Consent Medical functionality and market entry plan with Michelle Gallaher, ShareRoot CEO, over the past six months.

Gallaher said: “We are really delighted and fortunate to welcome Dr Chick to the board.

“Gaining access to Dr Chick’s investor network and know-how as well as his deep health technology development skills is a significant win for the company.”

Quick facts: Opyl Ltd

Price: 0.145 AUD

ASX:OPL

Market: ASX

Market Cap: $4.29 m

Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Opyl Ltd named herein, including the promotion by the Company of Opyl Ltd in any Content on the Site, the Company receives from said issuer...